It hadn’t occurred to me until I began speaking to the world’s leading myopia experts that I suffer from a disease. Least of all a preventable ­disease. Least of all a disease that if left to ...

Aims To investigate whether industry-sponsored randomised control trials (RCT) on myopia control have more favourable outcomes and differ in risk of bias, compared with studies having other sources of ...

Langis Michaud has received research funding from Bausch and Lomb, Neurolens and Fitlens. He has received speaker's fees from Johnson and Johnson and Essilor. Université de Montréal provides ...

Three studies showed that adults aged 20 to 50 years with myopia experienced about –1 D of progression. Most progression occurred between 20 and 30 years of age. Perspective from Alexander ...

Myopia is a refractive error (blurred vision at a given distance) that affects about 30% of the world's population. This proportion is increasing so quickly that it ...

Myopic macular degeneration (MMD) is a serious eye condition that can cause vision loss that gets worse over time. Treatment may help reduce complications of MMD. Myopic macular degeneration (MMD ...

The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for SYD-101 (atropine sulfate) to slow the progression of myopia in children. Considered a common ...

If approved, SYD-101 would be the first pharmaceutical treatment to slow the progression of pediatric myopia in the U.S. The FDA accepted a new drug application for SYD-101 to slow the progression ...

Purpose To investigate the predictive factors for myopic macular degeneration (MMD) and progression in adults with myopia. Methods We examined 828 Malay and Indian adults (1579 myopic eyes) with ...

A pair of University of Houston optometry researchers is warning against the use of low-level red light (LLRL) therapy as a method to control myopia, or nearsightedness, especially in children. Over ...